BiotechTube

Paxalisib + Opdualag + Irinotecan (drug) + Temozolomide (TMZ)

Phase 1/2Recruiting
0 watching 0 views this week⚡ Active
40
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Childhood Cancer

Conditions

Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor, Recurrent Cancer, Refractory Cancer

Trial Timeline

Jul 10, 2024 → Dec 1, 2035

NCT ID
NCT06208657

About Paxalisib + Opdualag + Irinotecan (drug) + Temozolomide (TMZ)

Paxalisib + Opdualag + Irinotecan (drug) + Temozolomide (TMZ) is a phase 1/2 stage product being developed by Bristol Myers Squibb for Childhood Cancer. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06208657. Target conditions include Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor.

Hype Score Breakdown

Clinical
13
Activity
8
Company
9
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT06208657Phase 1/2Recruiting

Competing Products

20 competing products in Childhood Cancer

See all competitors
ProductCompanyStageHype Score
LY2940680 + LY2940680Eli LillyPhase 1
33
Panobinostat + Cytarabine + PanobinostatNovartisPhase 1
33
Obinutuzumab + MMF + Prednisone + Methylprednisolone + Acetaminophen/ Paracetamol + Diphenhydramine HydrochlorideRochePhase 3
77
Rituximab + PlaceboRochePhase 2/3
65
BlinatumomabAmgenPhase 2
51
SemaglutideNovo NordiskApproved
84
Temsirolimus + Etoposide + Cyclophosphamide + Methotrexate + Hydrocortisone + CytarabinePfizerPhase 1
32
Talazoparib + Irinotecan + Temozolomide + Filgrastim + Peg-filgrastimPfizerPhase 1
32
CrizotinibPfizerPhase 1/2
40
Nivolumab + 5-azacytidineBristol Myers SquibbPhase 1/2
40
carboplatin + irinotecan hydrochlorideBristol Myers SquibbPhase 1
32
Vinblastine + Cyclophosphamide + Capecitabine + NivolumabBristol Myers SquibbPhase 1/2
40
Clofarabine incorporated into a 5-drug regimenSanofiPhase 1
32
Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
74
Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
74
BrivaracetamUCBPhase 3
74
Sodium OxybateJazz PharmaceuticalsPhase 1/2
38
Modified Measles Virus + Modified Measles Virus Lumbar PunctureBrain BiotechPhase 1
25
palbociclib isethionateBrain BiotechPhase 1
25
Cytarabine + Fludarabine + Hydrocortisone Sodium Succinate + Imetelstat + Leucovorin Calcium + MethotrexateGeronPhase 1
28

Other Products from Bristol Myers Squibb

DeucravacitinibApproved
84
Aripiprazole + Olanzapine + HaloperidolApproved
84
Irbesartan + CiprofibrateApproved
84
Entecavir + Lamivudine Placebo + Lamivudine + Entecavir PlaceboApproved
84
deucravacitinibApproved
84